Liberty Health Sciences Receives Processor Provisional License In the State Of Ohio

TORONTO, Oct. 18 2018 /PRNewswire/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) (“Liberty” or the “Company”), a provider of high quality cannabis, announced today that they have been awarded a Processor provisional license by the Ohio Department of Commerce. Liberty, along with their Ohio-based joint venture partner, the Schottenstein Group, will work on securing a Certificate of Operation over the next several months. The Processor provisional license follows the awarding of the Provisional dispensary license in June 2018 in the city of Dayton. Liberty owns 50.1% of both the Processor provisional license and the Provisional dispensary license with the Schottenstein Group owning the remaining 49.9%.

We are extremely pleased to be able to bring our high-quality medical cannabis processing methods to the citizens of Ohio. The state of Ohio represents a great opportunity for Liberty with our approach to providing quality product for patients in need. The list of approved conditions in the state under the medical cannabis program, results in a large potential patient base for Liberty.

George Scorsis, CEO of Liberty Health Sciences

Liberty currently processes a full range of products in their Florida operations ranging from tinctures to capsules and where it has established a track record for consistent high quality product for medical patients. Liberty will bring these same methods to Ohio and products to the extent that they are allowed for under the Ohio regulations.

“Our consumer is central to everything we do,” said George Scorsis. “Our priority is to provide the best possible solution to our patients which requires Liberty to be able to offer a full range of cannabis products to suit our customer’s specific needs. Our goal is for patients continue to come back to Liberty because of the consistent and dependable products we offer.”

About Liberty Health Sciences Inc.

Liberty is the cannabis provider committed to providing a trusted, high quality cannabis experience based on our genuine care for all cannabis users and a focus on operational excellence from seed to sale and beyond. Liberty’s measured approach to expansion opportunities maximizes returns to shareholders, while keeping consumers’ well-being at the forefront of what we do. For more information, please visit:

Original Press Release

Get ahead of the crowd by signing up for 420 Investor when it becomes available again. It’s the largest & most comprehensive premium service for cannabis investors since 2013.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter